Cite

HARVARD Citation

    Indini, A. et al. (2020). Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer. Expert opinion on pharmacotherapy. pp. 931-940. [Online]. 
  
Back to record